<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05004662</url>
  </required_header>
  <id_info>
    <org_study_id>MCC-20154</org_study_id>
    <secondary_id>5R01CA231952-03</secondary_id>
    <nct_id>NCT05004662</nct_id>
  </id_info>
  <brief_title>Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers</brief_title>
  <official_title>Partnering With a State Food Bank to Provide Tobacco Treatment to Underserved Smokers (Project NOURISH)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>H. Lee Moffitt Cancer Center and Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>H. Lee Moffitt Cancer Center and Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the efficacy and economic impact of a theoretically-based, fully&#xD;
      automated, interactive smartphone-based smoking cessation intervention.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 12, 2021</start_date>
  <completion_date type="Anticipated">October 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Self Reported 7 Day Abstinence Smoking Status</measure>
    <time_frame>12 Month Follow-Up</time_frame>
    <description>Participants will self report 7-day abstinence smoking status</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Smoking Status by Saliva Cotinine Kit</measure>
    <time_frame>12 Month Follow-Up</time_frame>
    <description>Investigators will verify smoking status by collecting cotinine sample from a saliva cotinine kit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self Reported 24 Hours Smoking Abstinence</measure>
    <time_frame>12 Month Follow-Up</time_frame>
    <description>Number of participants who report they quit smoking for 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 Day Smoking Abstinence</measure>
    <time_frame>12 Month Follow-Up</time_frame>
    <description>Number of participants who report they quit smoking for 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Continuous Smoking Abstinence</measure>
    <time_frame>12 Month Follow-Up</time_frame>
    <description>Number of participants who report they quit smoking</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Smoking Cessation</condition>
  <arm_group>
    <arm_group_label>Standard Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants randomized to Standard Treatment (ST) will be provided with a 10-week supply of nicotine patches and lozenges. ST participants will be connected with Florida Quitline services and will complete weekly 4-item smartphone assessments electronically for 26 weeks. The weekly assessments consist of questions on smoking status, motivation, self-efficacy, and perceived stress.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Automated Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants randomized to Automated Treatment (AT) will be given a 10-week supply of nicotine patches and lozenges. AT will also comprise of: 1) 12 proactive treatment videos, delivered weekly, that are tailored on smoking status, motivation, agency, and/or negative affect/stress; 2) 26 weeks of on-demand access to treatment content; 3) 26 weeks of text content</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Smartphone-delivered automated treatment</intervention_name>
    <description>An interactive smartphone-based intervention that comprises content delivered via audio/video clips and text content automatically each week to the participant</description>
    <arm_group_label>Automated Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine patch</intervention_name>
    <description>Participants will be provided with a 10-week supply of nicotine patches</description>
    <arm_group_label>Automated Treatment</arm_group_label>
    <arm_group_label>Standard Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Counceling</intervention_name>
    <description>Phone counseling with the Florida Quitline</description>
    <arm_group_label>Standard Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine lozenge</intervention_name>
    <description>Participants will be provided with a 10-week supply of nicotine lozenges</description>
    <arm_group_label>Automated Treatment</arm_group_label>
    <arm_group_label>Standard Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  &gt;100 lifetime cigarettes&#xD;
&#xD;
          -  English or Spanish speaking&#xD;
&#xD;
          -  Currently smoke &gt; 5 cigarettes/day&#xD;
&#xD;
          -  Willing to make a quit attempt within 1 week of enrollment&#xD;
&#xD;
          -  Process a smartphone compatible with the project app&#xD;
&#xD;
          -  Have a valid email address&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Medical condition that precludes use of Nicotine Replacement Therapy&#xD;
&#xD;
          -  Current use of smoking cessation medications&#xD;
&#xD;
          -  Enrolled in a smoking cessation study&#xD;
&#xD;
          -  Household member enrolled in the study&#xD;
&#xD;
          -  Inadequate health literacy&#xD;
&#xD;
          -  Failure to electronically confirm participation with 7 days of randomization via&#xD;
             electronic link sent to participant's smartphone&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Damon J Vidrine, Dr.PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Moffitt Cancer Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jennifer I Vidrine, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Moffitt Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristina Bowles</last_name>
    <phone>813-745-6239</phone>
    <email>Kristina.Bowles@moffitt.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Moffitt Cancer Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristina Bowles</last_name>
      <phone>813-745-6239</phone>
      <email>Kristina.Bowles@moffitt.org</email>
    </contact>
    <investigator>
      <last_name>Damon J Vidrine, Dr.PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jennifer I Vidrine, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steven Sutton, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 6, 2021</study_first_submitted>
  <study_first_submitted_qc>August 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2021</study_first_posted>
  <last_update_submitted>November 12, 2021</last_update_submitted>
  <last_update_submitted_qc>November 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

